AstraZeneca Admits in Court Documents That COVID-19 Vaccine Could Cause Serious Rare Side Effect

COVID-19 Vaccine

British pharmaceutical company AstraZeneca admitted in court documents for the first time that its COVID-19 vaccine could cause a rare blood-clotting side effect. 

The company is facing accusations that its vaccine contributed to the deaths or impairments of more than 50 people in the United Kingdom whose family are suing the pharmaceutical company. One claimant named Jamie Scott alleged the vaccine caused a permanent brain injury after a blood clot traveled to his brain. Scott claims he can no longer work because of the injury. 

Read More

COVID Vaccine ‘Adverse Events of Special Interest’ More Common than Expected: CDC-Funded Study

COVID Vaccine

Rep. Debbie Dingell developed a severe nerve condition from a mandatory swine flu vaccine, which initially made her “scared to death” to get a COVID-19 vaccine, she told a congressional hearing last week. 

The Michigan Democrat might want to reconsider her now-unquestioning enthusiasm for COVID vaccines, including those made through traditional methods, in light of a massive international study of “adverse events of special interest” funded by the Centers for Disease Control and Prevention and set to be published in the peer-reviewed Elsevier journal Vaccine.

Read More

Massive Pharma Company Exec: We Want to ‘Love the Communist Party’

Pharmaceutical giant AstraZeneca’s China president and global executive vice president pledged that the company would be patriotic in China and “love” the country’s ruling communist party, according to Reuters.

“Build a local, transnational company that loves the Communist Party and loves the country,” Wang Lei said, according to Reuters.

Read More

United Kingdom Approves AstraZeneca Coronavirus Vaccine

The United Kingdom became the first country to approve AstraZeneca’s coronavirus vaccine as the nation combats a sharp spike in confirmed cases.

The vaccine, developed in partnership with Oxford University, can be stored at much warmer temperatures than other approved candidates. Its approval followed an official recommendation from Britain’s Medicines and Healthcare Products Regulatory Agency, and the country has already purchased 100 million doses, the company said in its statement.

Read More

AstraZeneca, Johnson and Johnson Resuming U.S. Tests of COVID-19 Vaccines

Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.

Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data.

Read More

NIH: Halted Vaccine Study Shows ‘No Compromises’ on Safety

The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.
AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer’s illness is a side effect or a coincidence.

Read More